Bertrand COIFFIER, MD
Lymphoma Study Association · Hospices Civils de Lyon · Hospices Civils de Lyon, Lyon, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Bertrand COIFFIER, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:35 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00847223 · Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell LymphomaLymphoma Study Association · terminated · Mantle Cell Lymphoma · principal investigator
- Ph2NCT00498043 · A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in LymphomaHospices Civils de Lyon · completed · Lymphoma, B-Cell, Lymphoma, Large-Cell, Diffuse · principal investigator
- Ph3NCT00140569 · Randomized Study for Patients With Follicular Lymphoma Needing TreatmentLymphoma Study Association · completed · Follicular Lymphoma · study chair
- Ph2NCT00136565 · Study of Bortezomib Combined With ACVBP in Peripheral T-cell LymphomaLymphoma Study Association · completed · Peripheral T-cell Lymphoma · study chair
- Ph2NCT00136591 · A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell LymphomaLymphoma Study Association · terminated · Follicular Lymphoma · study chair
- Ph3NCT00003924 · Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaLymphoma Study Association · unknown · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.